Related Experiment Video
Updated: May 18, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study
Sune F Nielsen1, Stig E Bojesen, Peter Schnohr
1Department of Clinical Biochemistry, 54M1, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730 Herlev, Denmark.
Insights
Elevated rheumatoid factor (RF) levels significantly increase the long-term risk of developing rheumatoid arthritis. Testing for RF may aid in early detection and referral for rheumatoid arthritis.
Area of Science:
- Rheumatology
- Immunology
- Epidemiology
Background:
- Rheumatoid factor (RF) is an autoantibody often found in patients with rheumatoid arthritis.
- The predictive value of elevated RF levels for the long-term development of rheumatoid arthritis in the general population requires further investigation.
Purpose of the Study:
- To determine if elevated plasma IgM rheumatoid factor (RF) concentrations are associated with the long-term development of rheumatoid arthritis (RA).
Main Methods:
- A prospective cohort study involving 9712 white Danish individuals from the general population was conducted.
- Participants were followed for up to 29 years, with baseline plasma RF levels categorized.
- Rheumatoid arthritis development was assessed based on baseline RF levels.
Main Results:
- A doubling in RF levels was associated with a 3.3-fold increased risk of developing RA.
- The cumulative incidence of RA increased significantly with higher RF categories (P<0.0001).
- Individuals with RF levels >100 IU/mL had a 26-fold increased risk of RA, with a 32% 10-year absolute risk in specific subgroups.
Conclusions:
- Elevated RF levels in the general population are strongly associated with a significantly increased long-term risk of developing RA.
- These findings suggest that RF testing could be a valuable tool for identifying individuals at high risk for RA.
- The results may inform revised guidelines for early rheumatologist referral and the establishment of early arthritis clinics.
Objective:
To test whether elevated concentration of rheumatoid factor is associated with long term development of rheumatoid arthritis.
Design:
A prospective cohort study, the Copenhagen City Heart Study. Blood was drawn in 1981-83, and participants were followed until 10 August 2010.
Setting:
Copenhagen general population.
Participants:
9712 white Danish individuals from the general population aged 20-100 years without rheumatoid arthritis at study entry.
Main Outcome Measures:
Rheumatoid arthritis according to baseline plasma IgM rheumatoid factor level categories of 25-50, 50.1-100, and >100, versus <25 IU/mL.
Results:
Rheumatoid factor levels were similar from age 20 to 100 years. During 187,659 person years, 183 individuals developed rheumatoid arthritis. In healthy individuals, a doubling in levels of rheumatoid factor was associated with a 3.3-fold (95% confidence interval 2.7 to 4.0) increased risk of developing rheumatoid arthritis, with a similar trend for most other autoimmune rheumatic diseases. The cumulative incidence of rheumatoid arthritis increased with increasing rheumatoid factor category (P(trend)<0.0001). Multivariable adjusted hazard ratios for rheumatoid arthritis were 3.6 (95% confidence interval 1.7 to 7.3) for rheumatoid factor levels of 25-50 IU/mL, 6.0 (3.4 to 10) for 50.1-100 IU/mL, and 26 (15 to 46) for >100 IU/mL, compared with <25 IU/mL (P(trend)<0.0001). The highest absolute 10 year risk of rheumatoid arthritis of 32% was observed in 50-69 years old women who smoked with rheumatoid factor levels >100 IU/mL.
Conclusion:
Individuals in the general population with elevated rheumatoid factor have up to 26-fold greater long term risk of rheumatoid arthritis, and up to 32% 10 year absolute risk of rheumatoid arthritis. These novel findings may lead to revision of guidelines for early referral to a rheumatologist and early arthritis clinics based on rheumatoid factor testing.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Relative Risk
